InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Marlio Charles Mosseri, a TenPercentOwner, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 33 open-market SEC Form 4 transactions: 33 purchases worth $6.7M and 0 sales worth $0, reported from Jun 15, 23 to Oct 27, 25. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 27, 25 | NVCTNuvectis Pharma, Inc. | BUY | 72.8K | $6.28 | $457K |
| Oct 24, 25 | NVCTNuvectis Pharma, Inc. | BUY | 35.0K | $6.15 | $215K |
| Oct 23, 25 | NVCTNuvectis Pharma, Inc. | BUY | 46.9K | $6.06 | $284K |
| Jun 20, 25 | NVCTNuvectis Pharma, Inc. | BUY | 5.6K | $7.99 | $45K |
| Jun 18, 25 | NVCTNuvectis Pharma, Inc. | BUY | 28.0K | $8.05 | $226K |
| Jun 17, 25 | NVCTNuvectis Pharma, Inc. | BUY | 5.4K | $8.11 | $44K |
| May 12, 25 | NVCTNuvectis Pharma, Inc. | BUY | 21.2K | $8.11 | $172K |
| May 9, 25 | NVCTNuvectis Pharma, Inc. | BUY | 9.8K | $8.98 | $88K |
| May 8, 25 | NVCTNuvectis Pharma, Inc. | BUY | 2.4K | $8.97 | $22K |
| May 7, 25 | NVCTNuvectis Pharma, Inc. | BUY | 9.6K | $8.64 | $83K |
| May 6, 25 | NVCTNuvectis Pharma, Inc. | BUY | 10.1K | $8.64 | $87K |
| Feb 7, 25 | NVCTNuvectis Pharma, Inc. | BUY | 240.0K | $5.00 | $1.2M |
| Dec 13, 24 | NVCTNuvectis Pharma, Inc. | BUY | 17.0K | $4.70 | $80K |
| Dec 12, 24 | NVCTNuvectis Pharma, Inc. | BUY | 32.1K | $4.64 | $149K |
| Jul 31, 23 | NVCTNuvectis Pharma, Inc. | BUY | 860 | $13.88 | $12K |
| Jul 28, 23 | NVCTNuvectis Pharma, Inc. | BUY | 2.6K | $13.91 | $36K |
| Jul 27, 23 | NVCTNuvectis Pharma, Inc. | BUY | 1.6K | $13.98 | $22K |
| Jul 26, 23 | NVCTNuvectis Pharma, Inc. | BUY | 10.0K | $13.97 | $140K |
| Jul 21, 23 | NVCTNuvectis Pharma, Inc. | BUY | 2.8K | $14.61 | $42K |
| Jul 20, 23 | NVCTNuvectis Pharma, Inc. | BUY | 5.4K | $14.40 | $78K |
| Jul 19, 23 | NVCTNuvectis Pharma, Inc. | BUY | 8.0K | $14.84 | $119K |
| Jul 18, 23 | NVCTNuvectis Pharma, Inc. | BUY | 9.1K | $14.84 | $136K |
| Jul 12, 23 | NVCTNuvectis Pharma, Inc. | BUY | 3.3K | $15.09 | $50K |
| Jul 11, 23 | NVCTNuvectis Pharma, Inc. | BUY | 10.0K | $15.36 | $154K |
| Jul 7, 23 | NVCTNuvectis Pharma, Inc. | BUY | 8.9K | $15.19 | $136K |
| Jul 6, 23 | NVCTNuvectis Pharma, Inc. | BUY | 3.2K | $15.01 | $48K |
| Jul 5, 23 | NVCTNuvectis Pharma, Inc. | BUY | 1.2K | $15.52 | $18K |
| Jun 26, 23 | NVCTNuvectis Pharma, Inc. | BUY | 16.8K | $16.46 | $276K |
| Jun 23, 23 | NVCTNuvectis Pharma, Inc. | BUY | 73.2K | $17.43 | $1.3M |
| Jun 22, 23 | NVCTNuvectis Pharma, Inc. | BUY | 7.0K | $17.73 | $124K |
| Jun 21, 23 | NVCTNuvectis Pharma, Inc. | BUY | 6.1K | $17.71 | $108K |
| Jun 16, 23 | NVCTNuvectis Pharma, Inc. | BUY | 12.7K | $17.75 | $225K |
| Jun 15, 23 | NVCTNuvectis Pharma, Inc. | BUY | 31.7K | $17.71 | $562K |